Terns Pharmaceuticals Inc (430)

Currency in EUR
5.10
+0.18(+3.66%)
Closed·
430 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.805.10
52 wk Range
1.7710.20
Key Statistics
Bid/Ask
5.20 / 5.30
Prev. Close
4.86
Open
4.8
Day's Range
4.8-5.1
52 wk Range
1.77-10.2
Volume
66
Average Volume (3m)
887
1-Year Change
-15.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
430 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Terns Pharmaceuticals Inc Company Profile

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Compare 430 to Peers and Sector

Metrics to compare
430
Peers
Sector
Relationship
P/E Ratio
0.0x−0.7x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.5x2.6x
Price / LTM Sales
0.0x1.4x3.3x
Upside (Analyst Target)
0.0%315.3%43.4%
Fair Value Upside
Unlock−4.7%7.1%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

430 Income Statement

People Also Watch

9.070
CAPR
+12.39%
51.43
BMNR
+24.59%
9.720
ACHR
-0.82%
179.86
IQV
+0.51%

FAQ

What Stock Exchange Does Terns Pharmaceuticals Inc Trade On?

Terns Pharmaceuticals Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Terns Pharmaceuticals Inc?

The stock symbol for Terns Pharmaceuticals Inc is "430."

What Is the Terns Pharmaceuticals Inc Market Cap?

As of today, Terns Pharmaceuticals Inc market cap is 457.10M.

What Is Terns Pharmaceuticals Inc's Earnings Per Share (TTM)?

The Terns Pharmaceuticals Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 430 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Terns Pharmaceuticals Inc Stock Split?

Terns Pharmaceuticals Inc has split 0 times.

What is the current trading status of Terns Pharmaceuticals Inc (430)?

As of 10 Aug 2025, Terns Pharmaceuticals Inc (430) is trading at a price of 5.10, with a previous close of 4.86. The stock has fluctuated within a day range of 4.80 to 5.10, while its 52-week range spans from 1.77 to 10.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.